Sonoma Pharmaceuticals, Inc. — Director's Dealing 2018

Mar 2, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sonoma Pharmaceuticals, Inc. (SNOA)
CIK: 0001367083
Period of Report: 2018-03-01

Reporting Person: Birnbaum Jay E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-01	Common Stock, $0.0001 par value per share	A	1157	—	Acquired	50607	Direct

Footnotes

F1: The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan.